President Joe Biden is expected to sign the legislation, whose Senate sponsors cited ProPublica’s reporting on McKinsey’s conflicts in working for both the FDA and opioid makers like Purdue Pharma.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,